ArticleBrain, behavior, & immunity - health2026
Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization study.
Christina N Kushnir et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.